Brice P, Bastion Y, Lepage E, et al. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. J Clin Oncol. 1997. 15:1110-7.

Solal-Céligny P, Lepage E, Brousse N, Tendler CL, Brice P, Haïoun C, Gabarre J, Pignon B, Tertian G,Bouabdallah R, Rossi JF, Doyen C, Coiffier B. DOXOrubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial. J Clin Oncol. 1998 Jul;16(7):2332-8.

Dr. Pauline Brice

Groupe d'Etude des Lymphomes Folliculaires (GELF) Criteria

tumor

nodal

systemic

spleen

compress

pleural

leuk

cytopenia

Determines if immediate therapy for follicular lymphoma is required.

GELF Criteria for Follicular Lymphoma

Sagar Patel, MD, is currently a fellow in hematology and oncology at the Cleveland Clinic. A native of Minneapolis, he attended the University of Minnesota for both his medical school and internal medicine residency training. Dr. Patel’s areas of interest include health informatics and its advancement of clinical care and research realms. His disease research interests include leukemias, lymphomas, plasma cell neoplasms, and bone marrow transplantation.

Sagar Patel, MD

The Groupe d’Etude des Lymphomes Folliculaires (GELF) Criteria determines if immediate therapy for follicular lymphoma is required.

FLIPI for Follicular Lymphoma

MIPI

IPI and R-IPI

EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.

Listen to the VACO co-creators break down how to use VACO\, what it does\, and what it doesn’t.

Calc Function